Bharat Biotech to make antigen for first-ever anti-malaria vaccine
By IANS |
Published on
Wed, Jan 27 2021 18:42 IST |
0 Views
Over 60 envoys visit Bharat Biotech facility in Hyderabad. Image Source: IANS News
Hyderbad, Jan 27 : Global healthcare company GSK, non-profit agency working to end health inequity PATH, and vaccine maker Bharat Biotech on Wednesday announced the signing of a product transfer agreement for malaria vaccine RTS,S/AS01E1.
The agreement includes the transfer of manufacturing of the RTS,S antigen part of the vaccine and the grant of a license on all rights pertaining to the RTS,S/AS01 malaria vaccine to Hyderabad-based Bharat Biotech International Ltd (BBIL). GSK will retain the production of the adjuvant of the vaccine (AS01E) and will supply it to Bharat Biotech.
Representative image
HYDERABAD: Vaccine maker Bharat Biotech on Wednesday said it has entered into a product transfer agreement with pharma giant GSK and global non-profit PATH for the world’s only malaria vaccine RTS, S/AS01E1 that was developed by GSK.
The pact includes the transfer of manufacturing of the RTS, S antigen part of the vaccine as well as the grant of a licence on all rights pertaining to RTS, S/AS01 malaria vaccine to Bharat Biotech.
With this, by 2029, Bharat Biotech will be the sole supplier of the vaccine. However, GSK will retain production of the vaccine’s adjuvant AS01E, which it will supply to Bharat Biotech.
Updated Jan 14, 2021 | 20:00 IST
The Bharat Biotech CMD stressed that an international organisation (third party) is monitoring the entire conduct of the trial of Covaxin on a daily basis. Dr Krishna M Ella, CMD of Bharat Biotech in conversation with Editor in Chief Rahul Shivshankar
Key Highlights
Dr Krishna M Ella, CMD of Bharat Biotech, says Covaxin is safest coronavirus vaccine in the world Throwing stones at the start-ups and innovators of this country : Bharat Biotech CMD slams Congress over criticism of their vaccine
New Delhi: Dr Krishna M Ella, CMD of Bharat Biotech on Thursday slammed the Congress party over the criticism of its coronavirus vaccine by some of its leaders saying that COVAXIN , indigenous Covid vaccine developed by the company, is the safest in the world.